Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00096148
Status:
TERMINATED
Last Update Posted:
2013-01-24
First Post:
2004-11-09
Brief Title:
Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies |
| Adult Acute Basophilic Leukemia |
| Adult Acute Eosinophilic Leukemia |
| Adult Acute Megakaryoblastic Leukemia M7 |
| Adult Acute Minimally Differentiated Myeloid Leukemia M0 |
| Adult Acute Monoblastic Leukemia M5a |
| Adult Acute Monocytic Leukemia M5b |
| Adult Acute Myeloblastic Leukemia With Maturation M2 |
| Adult Acute Myeloblastic Leukemia Without Maturation M1 |
| Adult Acute Myeloid Leukemia With 11q23 MLL Abnormalities |
| Adult Acute Myelomonocytic Leukemia M4 |
| Adult Erythroleukemia M6a |
| Adult Pure Erythroid Leukemia M6b |
| Childhood Acute Basophilic Leukemia |
| Childhood Acute Eosinophilic Leukemia |
| Childhood Acute Erythroleukemia M6 |
| Childhood Acute Megakaryocytic Leukemia M7 |
| Childhood Acute Monoblastic Leukemia M5a |
| Childhood Acute Monocytic Leukemia M5b |
| Childhood Acute Myeloblastic Leukemia With Maturation M2 |
| Childhood Acute Myeloblastic Leukemia Without Maturation M1 |
| Childhood Acute Myelomonocytic Leukemia M4 |
| Secondary Acute Myeloid Leukemia |
| Untreated Adult Acute Myeloid Leukemia |
Keywords: